Haptoglobin polymorphism is not associated with prostate cancer in blacks

Area of Science:

• Genetics and Molecular Biology
• Oncology
• Biochemistry

Background:

• Prostate cancer (Pca) disproportionately affects Black men, with oxidative stress implicated in its development.
• Haptoglobin (Hp) is a polymorphic protein that mitigates oxidative stress from hemoglobin, with its antioxidant capacity being genetically determined.
• Understanding the role of Hp polymorphism in Pca susceptibility is crucial given the disease's burden.

Purpose of the Study:

• To investigate the association between haptoglobin (Hp) polymorphism and susceptibility to prostate cancer (Pca).
• To determine if Hp phenotype influences the risk or outcome of Pca.

Main Methods:

• A case-control study involving 201 participants: 60 controls, 62 benign prostate hypertrophy (BPH) patients, and 79 Pca patients.
• Serum prostate-specific antigen (PSA) levels were measured.
• Haptoglobin (Hp) phenotypes were determined using starch gel electrophoresis.

Main Results:

• Serum PSA levels were significantly elevated in BPH and Pca patients compared to controls.
• The distribution of Hp phenotypes (Hp 1-1, Hp 2-1, Hp 2-2) and anhaptoglobinemia did not differ significantly across control, BPH, and Pca groups.
• Hp1 allele frequency showed no significant variation based on disease status.

Conclusions:

• Haptoglobin (Hp) polymorphism is not associated with an increased risk of developing prostate cancer (Pca).
• Hp polymorphism does not appear to influence the outcome of prostate cancer (Pca).
• Further research may explore other genetic or environmental factors in Pca development.